Annual Operating Profit
-$42.00 M
-$5.26 M-14.33%
September 30, 2024
Summary
- As of February 22, 2025, CTXR annual operating income is -$42.00 million, with the most recent change of -$5.26 million (-14.33%) on September 30, 2024.
- During the last 3 years, CTXR annual operating profit has fallen by -$18.46 million (-78.46%).
- CTXR annual operating profit is now -214163.78% below its all-time high of -$19.60 thousand, reached on September 30, 2012.
Performance
CTXR Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$10.04 M
+$1.01 M+9.15%
December 31, 2024
Summary
- As of February 22, 2025, CTXR quarterly operating income is -$10.04 million, with the most recent change of +$1.01 million (+9.15%) on December 31, 2024.
- Over the past year, CTXR quarterly operating profit has increased by +$594.60 thousand (+5.59%).
- CTXR quarterly operating profit is now -1673166.67% below its all-time high of -$600.00, reached on December 31, 2012.
Performance
CTXR Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$42.69 M
-$698.80 K-1.66%
December 31, 2024
Summary
- As of February 22, 2025, CTXR TTM operating income is -$42.69 million, with the most recent change of -$698.80 thousand (-1.66%) on December 31, 2024.
- Over the past year, CTXR TTM operating profit has dropped by -$1.62 million (-3.96%).
- CTXR TTM operating profit is now -474283.33% below its all-time high of -$9000.00, reached on December 31, 2010.
Performance
CTXR TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
CTXR Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -14.3% | +5.6% | -4.0% |
| 3 y3 years | -78.5% | +5.6% | -4.0% |
| 5 y5 years | -169.2% | +5.6% | -4.0% |
CTXR Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -78.5% | at low | -38.5% | +9.2% | -73.3% | at low |
| 5 y | 5-year | -169.2% | at low | -142.5% | +9.2% | -164.0% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | +9.2% | <-9999.0% | at low |
Citius Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | -$10.04 M(-9.1%) | -$42.69 M(+1.7%) |
| Sep 2024 | -$42.00 M(+14.3%) | -$11.05 M(+3.9%) | -$42.00 M(+2.3%) |
| Jun 2024 | - | -$10.63 M(-3.1%) | -$41.07 M(+5.0%) |
| Mar 2024 | - | -$10.97 M(+17.4%) | -$39.11 M(+0.7%) |
| Dec 2023 | - | -$9.34 M(-7.7%) | -$38.82 M(+5.7%) |
| Sep 2023 | -$36.73 M(+10.3%) | -$10.12 M(+16.8%) | -$36.73 M(+7.5%) |
| Jun 2023 | - | -$8.67 M(-18.8%) | -$34.16 M(-0.7%) |
| Mar 2023 | - | -$10.69 M(+47.4%) | -$34.40 M(+9.9%) |
| Dec 2022 | - | -$7.25 M(-4.0%) | -$31.31 M(-6.0%) |
| Sep 2022 | - | -$7.55 M(-15.3%) | -$33.32 M(+7.6%) |
| Sep 2022 | -$33.32 M(+41.6%) | - | - |
| Jun 2022 | - | -$8.92 M(+17.5%) | -$30.97 M(+10.5%) |
| Mar 2022 | - | -$7.59 M(-18.0%) | -$28.04 M(+13.8%) |
| Dec 2021 | - | -$9.26 M(+78.0%) | -$24.63 M(+4.7%) |
| Sep 2021 | -$23.53 M(+32.9%) | -$5.20 M(-13.1%) | -$23.53 M(+4.7%) |
| Jun 2021 | - | -$5.98 M(+42.9%) | -$22.47 M(+6.1%) |
| Mar 2021 | - | -$4.19 M(-48.7%) | -$21.17 M(-1.1%) |
| Dec 2020 | - | -$8.16 M(+97.0%) | -$21.42 M(+20.9%) |
| Sep 2020 | -$17.71 M(+13.5%) | -$4.14 M(-11.7%) | -$17.71 M(+2.8%) |
| Jun 2020 | - | -$4.69 M(+5.8%) | -$17.23 M(+1.5%) |
| Mar 2020 | - | -$4.43 M(-0.3%) | -$16.96 M(+4.9%) |
| Dec 2019 | - | -$4.45 M(+21.6%) | -$16.17 M(+3.7%) |
| Sep 2019 | -$15.60 M(+13.1%) | -$3.66 M(-17.4%) | -$15.60 M(-0.0%) |
| Jun 2019 | - | -$4.43 M(+21.5%) | -$15.60 M(+18.3%) |
| Mar 2019 | - | -$3.64 M(-6.0%) | -$13.19 M(-8.5%) |
| Dec 2018 | - | -$3.87 M(+5.8%) | -$14.42 M(+4.6%) |
| Sep 2018 | -$13.79 M | -$3.66 M(+81.4%) | -$13.79 M(+10.0%) |
| Jun 2018 | - | -$2.02 M(-58.5%) | -$12.53 M(-1.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$4.87 M(+50.1%) | -$12.77 M(+22.2%) |
| Dec 2017 | - | -$3.24 M(+35.0%) | -$10.44 M(+4.6%) |
| Sep 2017 | -$9.99 M(+34.1%) | -$2.40 M(+6.5%) | -$9.99 M(-9.1%) |
| Jun 2017 | - | -$2.26 M(-11.3%) | -$10.99 M(+1.2%) |
| Mar 2017 | - | -$2.54 M(-8.7%) | -$10.86 M(+20.8%) |
| Dec 2016 | - | -$2.78 M(-18.2%) | -$8.99 M(+20.7%) |
| Sep 2016 | -$7.45 M(+130.6%) | -$3.41 M(+60.2%) | -$7.45 M(+48.7%) |
| Jun 2016 | - | -$2.13 M(+216.6%) | -$5.01 M(+37.0%) |
| Mar 2016 | - | -$671.60 K(-46.0%) | -$3.66 M(+1.7%) |
| Dec 2015 | - | -$1.24 M(+28.5%) | -$3.60 M(+11.3%) |
| Sep 2015 | -$3.23 M(>+9900.0%) | -$968.40 K(+25.2%) | -$3.23 M(+42.8%) |
| Jun 2015 | - | -$773.70 K(+27.1%) | -$2.26 M(+51.9%) |
| Mar 2015 | - | -$608.90 K(-30.7%) | -$1.49 M(+60.1%) |
| Dec 2014 | - | -$878.90 K(>+9900.0%) | -$930.00 K(+64.6%) |
| Jun 2014 | - | -$1300.00(-97.4%) | -$565.00 K(-0.4%) |
| Mar 2014 | - | -$49.80 K(-90.0%) | -$567.10 K(+7.7%) |
| Dec 2013 | - | -$499.20 K(+3295.9%) | -$526.60 K(+1780.7%) |
| Sep 2013 | -$28.10 K(+43.4%) | -$14.70 K(+332.4%) | -$28.00 K(+57.3%) |
| Jun 2013 | - | -$3400.00(-63.4%) | -$17.80 K(-13.6%) |
| Mar 2013 | - | -$9300.00(+1450.0%) | -$20.60 K(+14.4%) |
| Dec 2012 | - | -$600.00(-86.7%) | -$18.00 K(-8.2%) |
| Sep 2012 | -$19.60 K(-23.4%) | -$4500.00(-27.4%) | -$19.60 K(+12.0%) |
| Jun 2012 | - | -$6200.00(-7.5%) | -$17.50 K(-4.9%) |
| Mar 2012 | - | -$6700.00(+204.5%) | -$18.40 K(-2.1%) |
| Dec 2011 | - | -$2200.00(-8.3%) | -$18.80 K(-26.6%) |
| Sep 2011 | -$25.60 K | -$2400.00(-66.2%) | -$25.60 K(+10.3%) |
| Jun 2011 | - | -$7100.00(0.0%) | -$23.20 K(+44.1%) |
| Mar 2011 | - | -$7100.00(-21.1%) | -$16.10 K(+78.9%) |
| Dec 2010 | - | -$9000.00 | -$9000.00 |
FAQ
- What is Citius Pharmaceuticals annual operating income?
- What is the all time high annual operating profit for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals annual operating profit year-on-year change?
- What is Citius Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals quarterly operating profit year-on-year change?
- What is Citius Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals TTM operating profit year-on-year change?
What is Citius Pharmaceuticals annual operating income?
The current annual operating profit of CTXR is -$42.00 M
What is the all time high annual operating profit for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high annual operating income is -$19.60 K
What is Citius Pharmaceuticals annual operating profit year-on-year change?
Over the past year, CTXR annual operating income has changed by -$5.26 M (-14.33%)
What is Citius Pharmaceuticals quarterly operating income?
The current quarterly operating profit of CTXR is -$10.04 M
What is the all time high quarterly operating profit for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high quarterly operating income is -$600.00
What is Citius Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, CTXR quarterly operating income has changed by +$594.60 K (+5.59%)
What is Citius Pharmaceuticals TTM operating income?
The current TTM operating profit of CTXR is -$42.69 M
What is the all time high TTM operating profit for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high TTM operating income is -$9000.00
What is Citius Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, CTXR TTM operating income has changed by -$1.62 M (-3.96%)